Novella

Overview
News
Alternative Ingredients?
Product stageSegments
Minimum Viable Product
?
Cell-cultured and fermented protein ingredients
?

Novella is an Israel-based startup producing cultured plant-derived nutraceutical ingredients.

Novella’s process begins by selecting the optimal plant tissue from stems, fruits, leaves, and flowers and determining the stage of development for maximum micronutrient concentration. Instead of extraction, the company screens the plant tissues to pinpoint areas with the highest concentration of compounds, then grows the selected cells in a closed, controlled system that stimulates natural propagation. The process also eliminates exposure to pesticides and herbicides common in field-based agriculture. The cells are then converted into a nutritious and bio-accessible powder without the use of solvents.

In October 2023, Novella unveiled prototypes of its new line of cell-cultured berry-derived bioactives and expected to get to market in late 2025 or early 2026. The company also operates a pilot facility for the cultivation of whole-berry fruit cells from five varieties. 

HQ location:
Modi'in ISR
Founded year:
2022
Employees:
1-10
IPO status:
Private
Total funding:
-
Last Funding:
-
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.